madhurimaadvisors@gmail.com

+91 9839073390,  9839273000,

SCHEDULE A MEETING

FINANCIAL VIDEO

CLIENT SPEAK

Our company is a personal finance service provider to individuals and corporates. We are in business of advising, executing and managing portfolio within carefully designed process framework in order to build wealth and save money for our customers. We act as the single-point service provider where all financial, investment and tax planning services are offered under one roof. The company has strong leadership team with a history of entrepreneurial and management success.

Welcome To Madhurima Advisors
Madhurima Advisors is a Wealth Management Firm whose inclusive and sensible strategy have won many trusted relationships with High Net Worth Individuals, Corporate, Trusts and Institutions due to our ability to analyse and understand the Investment Needs of our clientele. We are fast growing firm guided by our ethics and morals working in the field of financial services since 2010 and a single point contact for all your investment and financial needs. We keep on reviewing our work to ensure to achieve best practices in terms of transparency and accountability. The foundation of our business conducts requires honesty, confidentiality and integrity in all matters. Financial Planning is the process of meeting your life goals through proper asset allocation. In simple words, its a blue print which can help you to achieve your goals and objectives for the future.We are well focused and provide need based services to people as per their specific requirements.

Read More..

MARKET WATCH

  • MF News
  • IPO News

Mutual Fund industry adds 5.6 lakh folios in July, debt funds gain traction  According to data from Association of Mutual Funds in India, the number of folios with 45 fund houses rose to 9,21,05,737 at the end of last month, from 9,15,42,092 at June-end, registering a gain of 5.63 lakh folios.
Fri, 14 Aug 2020 15:07:08 +0530


Subscribe to Burger King India: Mehta Equities Mehta Equities has come out with its report on Burger King India. The research firm has recommended to #39;#39;Subscribe#39;#39; the ipo in its research report as on December 01, 2020.
Tue, 01 Dec 2020 15:29:09 +0530


Subscribe to Burger King India: Prabhudas Lilladher Prabhudas Lilladher has come out with its report on Burger King India. The research firm has recommended to #39;#39;Subscribe#39;#39; the ipo in its research report as on November 30, 2020.
Mon, 30 Nov 2020 21:22:32 +0530


Gland Pharma shares rally 21%, close at Rs 1,820 on listing day Gland Pharma traded with volume of 7,87,955 equity shares on the BSE and 1,13,10,647 shares on the NSE. The market capitalisation stood at Rs 29,725 crore.
Fri, 20 Nov 2020 18:08:01 +0530


Gland Pharma shares debut at Rs 1,710, a 14% premium over issue price Fosun Singapore and Shanghai Fosun Pharma are the promoters of the company. Their shareholding reduced to 58 percent in the company from 74 percent post issue.
Fri, 20 Nov 2020 10:00:32 +0530


Subscribe to Gland Pharma: Geojit Geojit has come out with its report on Gland Pharma. The research firm has recommended to #39;#39;Subscribe#39;#39; the ipo in its research report as on November 07, 2020
Tue, 10 Nov 2020 12:52:30 +0530


Subscribe to Gland Pharma: Nirmal Bang Nirmal Bang has come out with its report on Gland Pharma. The research firm has recommended to #39;#39;Subscribe#39;#39; the ipo in its research report as on November 09, 2020
Tue, 10 Nov 2020 12:44:08 +0530


Subscribe to Gland Pharma: KR Choksey KR Choksey has come out with its report on Gland Pharma. The research firm has recommended to #39;#39;Subscribe#39;#39; the ipo in its research report as on November 09, 2020
Tue, 10 Nov 2020 12:35:43 +0530


Subscribe to Gland Pharma: Hem Securities Hem Securities has come out with its report on Gland Pharma. The research firm has recommended to #39;#39;Subscribe#39;#39; the ipo in its research report as on November 09, 2020
Tue, 10 Nov 2020 12:24:57 +0530


Subscribe to Gland Pharma: ICICI Direct ICICI Direct has come out with its report on Gland Pharma. The research firm has recommended to #39;#39;Subscribe#39;#39; the ipo in its research report as on November 09, 2020
Tue, 10 Nov 2020 08:23:49 +0530


Business Insight | Ant Group set to surpass Saudi Aramco in record $34 billion IPO The listing is expected to be larger than oil giant Saudi Aramco#39;s $29 billion IPO in 2019
Tue, 27 Oct 2020 19:24:08 +0530